Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01060683
Other study ID # SpHb-001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2010
Est. completion date July 2011

Study information

Verified date April 2024
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the accuracy of continuous SpHb measurement ( Rainbow DCI, Masimo, Irvine Ca, USA) compared to the current method of monitoring (blood sampling), both during phases of hemoconcentration and hemodilution.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2011
Est. primary completion date July 2011
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients: Age > 18 years - ASA class I and II patient requiring hepatic resection Exclusion Criteria: - Patient refusal - Patients with a perioperative blood loss exceeding 5ml/kg

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Hemoglobin determination + NaCl 0.9% bolus

hemoglobin determination + Venofundin bolus


Locations

Country Name City State
Netherlands University Medical Center Groningen,University of Groningen, the Netherlands Groningen

Sponsors (1)

Lead Sponsor Collaborator
University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the accuracy of continuous SpHb measurement during hepatic resection compared with standard (invasive) Hb measurement during operation
Secondary the effect of a bolus of crystalloid on SpHb level will be compared to the effect of a bolus of colloid on the SpHb level. during operation